Chemi Nutra has introduced a liquid, 100% water dispersible, stable, and patented form of Mediator Phosphatidic Acid (PA), called VitaSperse-PA.
Photo © Shutterstock.com/Mariyana M
Chemi Nutra (Austin, TX) has introduced a liquid, 100% water dispersible, stable, and patented form of Mediator Phosphatidic Acid (PA), called VitaSperse-PA. Mediator PA has a proven mechanism of action, where it activates and sustains mTOR signaling, which rapidly upregulates muscle protein synthesis and lipid metabolism. Research has shown that it can accelerate muscle mass and strength gains, as well as fat mass loss in men and women. Until now, Mediator PA has been used in powder formulations, two-piece hard-shell capsules, and soft gel capsule, but could not be used in liquid applications because it is a lipid-based compound.
VitaSperse-PA was developed in collaboration with Ingredient Innovations International (DBA 3i Solutions; Wooster, OH), a leader in ingredient dispersion technology. “Almost 20 years ago we began working with 3i Solutions, as they perfected a 100% water soluble, stable, concentrated, highly bioavailable, form of our SerinAid PhosphatidylSerine (PS), which has been used for about 10 years in commercially sold mental performance beverages and shots,” said Scott Hagerman, president of Chemi Nutra, in a press release. “With 3i Solutions’ demonstrated capabilities and our combined applications and marketing work in functional drinks of all types, we are excited that our branded, clinically proven, Mediator PA can now be easily and effectively added to beverages, shots, liquids, and gels - a rapidly evolving segment in the functional foods arena.”
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.